How a Checklist Can Save Your Portfolio
In a complex investment world, make things simpler.
Billionaire Investors Favoring Health Care, M&A
Rate hike, or not? Overvalued market, or not? Despite the uncertainty, two sectors are attracting the attention of billionaire investors.
4 Predictions by Billionaires for 2015: Soros, Icahn, Others
Based on shareholder letters and other writings from George Soros, Carl Icahn, Steve Mandel and other billionaire investors, here are four things to expect.
Anyone Can Invest Like Buffett, Icahn With New ETF
Want a tip from Warren Buffett? New app provides instant notification of his SEC filings, and the accompanying ETF blends the 10 best performing billionaires.
NY Times: Down With Shareholder Democracy
Recent controversies involving Herbalife and Apple could be related to abuses aided by the shareholder democracy movement, according to The New York Times.
Buyer of the Overlooked and Unloved Embraces Apple
Considering that Morningstar ranks the Roumell Opportunistic Value Fund in the top 1% of its category, portfolio managers Jim Roumell and Ted Crawford may be on to something with their call on Apple.
Apple CEO: Shareholder Suit a ‘Silly Sideshow’
Apple CEO Tim Cook is calling a shareholder lawsuit against the company a "silly sideshow," even as he said he was open to looking at the shareholder's proposals for sharing more cash with investors.
Hedge Manager Einhorn to Apple: Show Me the Cash
Einhorn says "several hundred dollars per share would be unlocked" if Apple were to follow his plan.
Hedge Fund Manager Einhorn Fined, Receives Personal Rebuke
Famed hedge fund manager and spurned New York Mets suitor David Einhorn saw a hit to his otherwise strong reputation Wednesday when Britain's Financial Services Authority announced it has fined his Greenlight Capital hedge fund, as well as Einhorn personally.
Outlook 2012: Key to Alternative Investing Is More Diversification
Last year's choices for top alternative investments didn't fare so well and a change to a more diversified strategy may be the way to go in 2012.